Repligen reported $284.62M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agilent A:US USD 2.97B 202M
Bio Techne TECH:US USD 200M 64.66M
Biomarin Pharmaceutical BMRN:US USD 1.09B 3.46M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Bruker BRKR:US USD 1.22B 65.4M
Catalent CTLT:US USD 4.85B 649M
Charles River Laboratories CRL:US USD 2.71B 227.93M
Danaher DHR:US USD 19.68B 430M
Dentsply International XRAY:US USD 1.94B 39M
Exact Sciences EXAS:US USD 2.25B 981K
Fluidigm FLDM:US USD 64.89M 174K
General Electric GE:US USD 32.35B 1.94B
Henry Schein HSIC:US USD 1.15B 104M
Illumina ILMN:US USD 2.74B 994M
IQVIA Holdings Inc IQV:US USD 12.75B 353M
Mettler Toledo International MTD:US USD 2.01B 35.64M
Nanostring Technologies NSTG:US USD 226.62M 372K
Orasure Technologies OSUR:US USD 1.68M 495K
Pacific Biosciences Of California PACB:US USD 896.68M 154K
Patterson Companies PDCO:US USD 662.91M 388K
Peregrine Pharmaceuticals PPHM:US USD 142.58M 136K
Perkinelmer PKI:US USD 4.39B 7.54M
Repligen RGEN:US USD 284.62M 450K
Thermo Fisher Scientific TMO:US USD 34.49B 5.33B
Waters WAT:US USD 1.57B 30.25M
West Pharmaceutical Services WST:US USD 208.9M 500K